Wird geladen...
5PSQ-084 Safety and effectiveness of switching to infliximab biosimilar in digestive and rheumatological pathology
BACKGROUND: The introduction of biosimilar drugs into clinical practice allows us to maintain the effectiveness and safety of treatments, taking greater advantage of health resources PURPOSE: The objective of the study was to evaluate the safety and effectiviness of infliximab biosimilar (IFXb) in p...
Gespeichert in:
| Veröffentlicht in: | Eur J Hosp Pharm |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Group
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535443/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.438 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|